Drug Patent Watch
APRIL 8, 2025
"5 Key Considerations for Valuing Pharma Companies As the pharmaceutical industry continues to evolve, accurately valuing pharma companies has become increasingly complex. At DrugPatentWatch, we've identified 5 key considerations that can help you make informed investment decisions. Patent Portfolio Strength : A strong patent portfolio can significantly impact a company's valuation.
Conversations in Drug Development Trends
APRIL 8, 2025
In a recent webinar, Challenges of Drug Development in Early Parkinsons Disease , Tom Babic, MD, PhD , our Vice President of Scientific Solutions in Neuroscience, uses his 40+ years of experience to share invaluable insights into the current state and future directions of early Parkinsons disease (PD) research. Although clinical research in PD began more than 25 years ago, there have been no significant updates in the last decade.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
APRIL 8, 2025
Patient Safety in the Era of Generic Drugs: A Call to Action As the pharmaceutical industry continues to evolve, one thing remains constant: the need for patient safety. With the rise of generic drugs, it's more important than ever to ensure that these alternatives meet the same high standards as their brand-name counterparts. At DrugPatentWatch, we've seen firsthand the impact that generic drugs can have on patients.
FDA Law Blog: Biosimilars
APRIL 8, 2025
By Kurt R. Karst The FDA Reduction-in-Force (Termination)or RIF(T)announced last week has resulted in countless stories in the press and on personal LinkedIn accounts from those RIFd. As the dust begins to settle and we all assess what this means for the future of FDA and the public health, generally, this blogger wanted to call out one particular division in the Office of Generic Drugs (OGD), funded by user fees under the Generic Drug User Fee Amendments (GDUFA), that was eradicated and what t
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
ProRelix Research
APRIL 8, 2025
Struggling with multi-country clinical trials? Overcome regulatory hurdles, patient recruitment challenges, and data complexities with a true CRO partner. Introduction Carrying out a multi-country clinical trial is indeed an arduous […] The post A True CRO Partner for Your Multi-Country Clinical Trial appeared first on ProRelix Research.
BioPharma Drive: Drug Pricing
APRIL 8, 2025
“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- The U.S. Senate has confirmed the appointment of Mehmet Oz, M.D., to head the Centers for Medicare & Medicaid Services (CMS), according to a report from The New York Times.The TV celebrity doctor and cardiothoracic.
Science Daily: Pharmacology News
APRIL 8, 2025
Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves neuron health in animal models of Alzheimer's disease, according to a new study.
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- U.S. Health Secretary Robert F. Kennedy Jr. says he will tell the U.S. Centers for Disease Control and Prevention (CDC) to stop recommending fluoride in drinking water across the country.He also announced plans to form a.
Science Daily: Pharmacology News
APRIL 8, 2025
The intermittent fasting diet, which involves periods of severe calorie restriction, may be on the way out, as research is suggesting that rather than drastically reducing calories, people can achieve similar metabolic benefits by cutting back on carbs.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- Tuberculosis (TB) might seem like a disease from days gone by, but a new study suggests the COVID pandemic might have given the infectious menace a new foothold.Most modern-day TB cases happen in prisons, where inmates in.
Science Daily: Pharmacology News
APRIL 8, 2025
Researchers discovered the blood vessels at the back of the eye -- called retinal microvasculature -- can show early signs someone is at risk of developing dementia.
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- Federal cuts to funding could decimate medical research in the United States, delaying cures and costing countless lives, according to a leader in cancer research.Theres been an overall freeze in funding from the Natio.
Science Daily: Pharmacology News
APRIL 8, 2025
Researchers report their discovery of fluorescent pigments in the feathers of Long-eared Owls, that can only be seen by humans with the help of ultraviolet light.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- A non-intoxicating extract of cannabis appears to help children and teenagers with autism, a new study says.Cannabidiol (CBD) enhanced social responsiveness, reduced disruptive behavior and alleviated anxiety among kids.
Science Daily: Pharmacology News
APRIL 8, 2025
A tiny, soft, flexible robot that can crawl through earthquake rubble to find trapped victims or travel inside the human body to deliver medicine may seem like science fiction, but an international team is pioneering such adaptable robots by integrating flexible electronics with magnetically controlled motion.
BioPharma Drive: Drug Pricing
APRIL 8, 2025
The company has decided to switch gears following disappointing data for a monoclonal antibody targeting a rare maternal blood disorder.
Science Daily: Pharmacology News
APRIL 8, 2025
Researchers formally describe Helmetia expansa, offering new insights into its anatomy, behavior and evolutionary relationships.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- Medicare Advantage plans are squeezing billions out of the federal government by billing more for patient care, a new study says.Medicare Advantage plans received an extra $33 billion in revenue from the feds in 2021 due.
Science Daily: Pharmacology News
APRIL 8, 2025
The idea that dinosaurs were already in decline before an asteroid wiped most of them out 66 million years ago may be explained by a worsening fossil record from that time rather than a genuine dwindling of dinosaur species, suggests a new study.
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- Cough? Sore throat? UTI? Eye infection?Artificial intelligence (AI) might one day be seeing you for these sorts of conditions, a new study says.AI programs appear to outperform human doctors when it comes to urgent care.
BioPharma Drive: Drug Pricing
APRIL 8, 2025
The company has decided to switch gears following disappointing data for a monoclonal antibody targeting a rare maternal blood disorder.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- Pregnancy might offer women some protection from developing long COVID, a new study says.Women infected with COVID-19 during pregnancy were 14% to 30% less likely to develop lasting symptoms from their illness, researchers.
Collaborative Drug
APRIL 8, 2025
Drug Discovery Industry Roundup with Barry Bunin April 8th, 2025
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- More than 212,000 pounds of liquid egg substitutes have been recalled because they may be contaminated with a cleaning solution that contains bleach.Cargill Kitchen Solutions, based in Lake Odessa, Mich., recalled the.
addgene Blog
APRIL 8, 2025
Ah, the notorious western blot : we meet again. So useful, yet so finicky to design and optimize. Today well cover the normalization and loading controls needed for relative quantification of a western blot and why you might want to be careful relying on so called housekeeping proteins.
Alta Sciences
APRIL 8, 2025
ISSUE NO. 43 Advancing Vision Care With Formulation and Manufacture of Ocular Therapeutics pmjackson Tue, 04/08/2025 - 15:28 According to the WHO, at least a billion people are currently living with vision impairment from a preventable or treatable source. Precedence Research reports that the global ophthalmic drug market size is estimated to double in 10 years, from $34.6 billion in 2021 to an estimated $68.93 billion by 2030.
Fierce BioTech
APRIL 8, 2025
Q&A with Tim Schroder, Chairman, CEO and Founder of CTI | CTI grew from a Cincinnati startup to a global leader in clinical research. CEO Tim Schroder shares insights on its success and whats next.
Science Daily: Pharmacology News
APRIL 8, 2025
Researchers estimated that smoke from wildfires and prescribed burns caused $200 billion in health damages in 2017, and that these were associated with 20,000 premature deaths. Senior citizens were harmed the most, and Native American and Black communities experienced the greatest damages per capita.
Fierce BioTech
APRIL 8, 2025
From Hit to IND: Streamlining Drug Discovery Through Multidisciplinary Integration pesurya Tue, 04/08/2025 - 12:08 Wed, 05/28/2025 - 11:00 Resource Type Webinar Subas Sakya, Ph.D. Babu Boga, Ph.D. Drug discovery is inherently a time-consuming and costly endeavor. How can todays new drug innovators accelerate their programs through a simple, fast, and streamlined processespecially when working with multiple vendors?
Drugs.com
APRIL 8, 2025
TUESDAY, April 8, 2025 -- Severe and possibly deadly strep infections are on the rise in the U.S., a study published Monday in Journal of the American Medical Association said.The rate of invasive group A strep infections more than doubled from.
Fierce BioTech
APRIL 8, 2025
Rethinking Drug Commercialization: Navigating a Shifting Biotech Investment Landscape swheeler Tue, 04/08/2025 - 16:40 Thu, 05/15/2025 - 12:00 Resource Type Webinar Susanne Munksted The biotech dealmaking landscape is changingdeals are happening later in development, and securing capital is tougher than ever. For biotech companies, especially those developing precision and rare disease therapies, this creates unexpected commercialization challenges with limited resources and expertise.
Expert insights. Personalized for you.
68 
Let's personalize your content